Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26467 http://scihub22266oqcxt.onion/10.1002/jmv.26467 32852080!7461379!32852080     free     free     free       J+Med+Virol 2021 ; 93 (2): 1180-1183 Nephropedia Template TP {{tp|p=32852080|t=2021. Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients |pdf=|usr=}}{{32852080}} gab.com Text Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32852080 #FOAvip To compare characteristics and outcomes of patients who had COVID-19 with Mycoplasma pneumoniae immunoglobulin M (IgM) antibodies to those without M. pneumoniae antibodies. We retrospectively reviewed cases admitted over a 4-week period between 17 March 2020 and 14 April 2020 to the Hoboken University Medical Center, NJ, USA. We compared the outcomes of COVID-19 patients who were positive for M. pneumoniae IgM with those who were negative for M. pneumoniae IgM. The primary outcome was mortality. The adjusted odds ratio was calculated after controlling for baseline differences. Of 139 patients admitted with COVID-19, 79 were positive for M. pneumoniae IgM. The mortality among those who were M. pneumoniae IgM positive was significantly higher (adjusted odds ratio: 2.28, 95% confidence interval: 1.03 to 5.03) compared with those who were M. pneumoniae IgM negative. Patients with coinfection (COVID-19 and mycoplasma) have higher mortality compared with patients with just COVID-19 disease. Twit Text FOAVip Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32852080 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32852080 #FOAvip English Wikipedia <ref>{{Cite pmid|32852080}}</ref> Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients #MMPMID32852080 Amin D; McKitish K; Shah PS J Med Virol 2021[Feb]; 93 (2): 1180-1183 PMID32852080show ga To compare characteristics and outcomes of patients who had COVID-19 with Mycoplasma pneumoniae immunoglobulin M (IgM) antibodies to those without M. pneumoniae antibodies. We retrospectively reviewed cases admitted over a 4-week period between 17 March 2020 and 14 April 2020 to the Hoboken University Medical Center, NJ, USA. We compared the outcomes of COVID-19 patients who were positive for M. pneumoniae IgM with those who were negative for M. pneumoniae IgM. The primary outcome was mortality. The adjusted odds ratio was calculated after controlling for baseline differences. Of 139 patients admitted with COVID-19, 79 were positive for M. pneumoniae IgM. The mortality among those who were M. pneumoniae IgM positive was significantly higher (adjusted odds ratio: 2.28, 95% confidence interval: 1.03 to 5.03) compared with those who were M. pneumoniae IgM negative. Patients with coinfection (COVID-19 and mycoplasma) have higher mortality compared with patients with just COVID-19 disease. |Aged[MESH] |Antibodies, Bacterial/*blood[MESH] |COVID-19/*complications[MESH] |Coinfection/immunology/*mortality[MESH] |Female[MESH] |Humans[MESH] |Immunoglobulin M/blood[MESH] |Male[MESH] |Middle Aged[MESH] |New Jersey[MESH] |Odds Ratio[MESH] |Pneumonia, Mycoplasma/*mortality/*virology[MESH]Association of mortality and recent Mycoplasma pneumoniae infection in(epmc).pdf DeepDyve Pubget Overpricing